Neurovations is focused on new and innovative clinical trials and treatments for chronic pain and neurologic disease. Founded by Eric Grigsby, MD, MBA, long-time leader in pain management, Neurovations enjoys a reputation for excellence decades in the making. Our team has led clinical trials for more than 25 companies in the fields of pain management and minimally invasive spine care, partnering with industry leaders and early-stage companies in medical device (Phase I-IV) and pharmaceutical trials (Phase II-IV).
We partner with our sister company, Neurovations Clinical Research, to offer our patients access to advanced new trial therapies for Chronic Pain.
Neurovations Knee Pain Study
We are currently enrolling patients in a new clinical study for moderate to severe knee pain to evaluate a very unique injection treatment. In this study, a tiny amount of DNA is placed in the knee, which may help your joint produce its own powerful, anti-inflammatory medication.
If you have moderate to severe knee pain from osteoarthritis, please reach out to us in Napa at Neurovations Research. We are the region’s most experienced clinical research facility for chronic pain.
If accepted for this study, you will receive free study-related medical care and be compensated for your travel time and expenses. To see if you qualify, call Neurovations Research at 707-252-9606 or click on the link below to email us.